IOVANCE BIOTHERAPEUTICS, INC. Balance Sheet
IOVA / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
IOVANCE BIOTHERAPEUTICS, INC. had $913M in total assets and $699M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163.1M | $115.7M | $114.9M | $231.7M | $78.2M | $67.3M | $14.0M | $82.2M | $145.4M | $106.7M | $33.6M | $44.9M | $19.7M | $0 | $510.2K |
| Accounts Receivable | $82.4M | $69.3M | $151.0K | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | $51.7M | $51.5M | $10.4M | - | - | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $442.7M | $457.0M | $307.8M | $479.1M | $508.0M | $636.1M | $316.5M | $475.4M | $149.3M | $169.5M | $104.0M | $45.0M | $19.8M | $7.3K | $524.1K |
| PP&E (Net) | $131.1M | $109.1M | $114.0M | $105.2M | $100.9M | $59.2M | $8.5M | $2.7M | $2.5M | $2.4M | $1.7M | $1.5M | $27.8K | $22.1K | $28.3K |
| Total Assets | $913.2M | $910.4M | $780.4M | $664.0M | $777.3M | $768.5M | $344.7M | $480.8M | $155.4M | $171.9M | $105.7M | $46.5M | $19.9M | $29.4K | $568.4K |
| Current Liabilities | $138.4M | $122.3M | $110.3M | $91.5M | $89.2M | $54.9M | $39.1M | $14.4M | $9.9M | $5.0M | $1.6M | $1.7M | $2.3M | $11.3M | $13.3M |
| Shareholders' Equity | $698.6M | $710.4M | $584.6M | $499.6M | $621.7M | $656.5M | $299.0M | $466.2M | $145.5M | $166.9M | $104.0M | $44.8M | $17.6M | -$11.3M | -$12.8M |